Synthetic pentapeptide produced by modification of melanocyte stimulating inhibitory factor. Prepn: H. B. Abajian, et al., WO 9530430; eidem, US 5589460 (1995, 1996 both to Innapharma). Structure activity study: J. J. Hlavka, J. Appl. Res. 2, 58 (2002). Clinical pharmacokinetics: J. P. Feighner et al., Biopharm. Drug Dispos.. 23, 33 (2002); G. Nicolau et al., ibid. 26, 379 (2005). Clinical evaluation: eidem, Int. J. Neuropsychopharmacol. 6, 207 (2003). Review of development and therapeutic potential: J. Dingemanse, Curr. Opin. Investig. Drugs 4, 859-862 (2003).
Antidepressant.
Antidepressant